• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

    29.17 +0.21 (+0.73%)
    Streaming Delayed Price Updated: 11:44 AM EST, Feb 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 201,559
    Open 28.69
    Bid (Size) 29.15 (200)
    Ask (Size) 29.25 (100)
    Prev. Close 28.96
    Today's Range 28.53 - 29.76
    52wk Range 27.80 - 75.29
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million ↗
    This healthcare technology firm develops robotic surgical systems for minimally invasive urology procedures targeting BPH treatment. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City
    From PROCEPT BioRobotics
    Via GlobeNewswire

    Performance

    YTD
    -5.2%
    -5.2%
    1 Month
    -5.2%
    -5.2%
    3 Month
    -15.5%
    -15.5%
    6 Month
    -41.2%
    -41.2%
    1 Year
    -59.1%
    -59.1%

    More News

    Read More
    News headline image
    3 Underrated Robotics Stocks Poised for Huge Gains ↗
    Via MarketBeat
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 6, 2025 ↗
    Via Benzinga
    News headline image
    Where PROCEPT BioRobotics Stands With Analysts ↗
    Via Benzinga
    News headline image
    PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    2 Robotics Stocks Riding the Sensor and Medical Boom ↗
    Via The Motley Fool
    News headline image
    Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? ↗
    Via The Motley Fool
    News headline image
    Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock ↗
    Via Benzinga
    News headline image
    PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts ↗
    Via Benzinga
    News headline image
    Procept (PRCT) Q2 Revenue Jumps 48% ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    PROCEPT BioRobotics (PRCT) Earnings Transcript ↗
    Via The Motley Fool
    Topics World Trade
    News headline image
    PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline ↗
    Via Chartmill
    News headline image
    PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    Uncovering Potential: PROCEPT BioRobotics's Earnings Preview ↗
    Via Benzinga
    News headline image
    PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
    From PROCEPT BioRobotics
    Via GlobeNewswire
    News headline image
    PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire

    Frequently Asked Questions

    Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?
    Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
    What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
    PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
    The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
    What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
    The current price of PROCEPT BioRobotics Corporation - Common Stock is 29.17
    When was PROCEPT BioRobotics Corporation - Common Stock last traded?
    The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 02/02/26 11:44 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.